Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep891 | Pituitary - Clinical | ECE2016

Non-alcoholic fatty liver disease in patients with biochemically cured Cushing’s disease and non-functioning pituitary adenomas: role of adrenal insufficiency and growth hormone deficiency

Auer Matthias K , Stieg Mareike R , Stalla Gunter K

Objective: Nonalcoholic fatty liver disease (NAFLD) is a hallmark of the metabolic syndrome and has been shown to be an independent predictor of cardiovascular mortality. Although glucocorticoids and growth hormone are known to be implicated in its pathophysiology, it has only rarely been investigated in the context of patients with pituitary insufficiency or former cortisol excess.Design: Case-control study, including patients with biochemically control...

ea0037gp.05.04 | Developmental and paediatric endocrinology | ECE2015

Pilot study on the effects of cross-sex hormone treatment in transsexual persons on metabolism by means of metabolomics profiling

Auer Matthias K , Xu Tao , Roepke Yasmin , Stalla Gunter K , Stieg Mareike , Van Caenegem Eva , Prehn Cornelia , Wang-Sattler Rui , Adamski Jerzy , T'sjoen Guy

Introduction: Sex steroid hormones exert a wide range of effects on metabolism. New techniques such as metabolomic profiling allow for a deeper insight into metabolic regulation. In epidemiological samples it has been demonstrated that most of these metabolites show sex-specific differences. However, if these differences are attributable to the effects of sex hormones or genetics is little understood so far.Methods: We performed targeted metabolomics pro...

ea0073aep6 | Adrenal and Cardiovascular Endocrinology | ECE2021

Salivary profiles of 11-oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia

Nowotny Hanna F. , Auer Matthias K. , Lottspeich Christian , Schmidt Heinrich , Dubinski Ilja , Bidlingmaier Martin , Adaway Jo , Hawley James , Keevil Brian , Reisch Nicole

BackgroundRoutine biochemical assessment in patients with congenital adrenal hyperplasia (CAH) includes measurement of serum 17–hydroxyprogesterone (17OHP), androstenedione (A4) and testosterone (T) and their metabolites in urine. Several studies have also described 11–oxygenated 19–carbon (110 × C19) steroids as a clinically relevant androgenetic source and highlighted their potential as markers for evaluation of adrenal androgen exc...